Absolutely. In terms of the treatment, certainly, I think the psychological treatment of anxiety, depression and these kinds of issues that people are presenting with are going to be beneficial. We're going to help people cope more effectively, regardless of the source of the anxiety.
It's not like that treatment is going to be wasted, but we might very well find that certain people are not responding as effectively to treatment as we might otherwise hope, and the mefloquine exposure and the reaction are in fact holding them back. What do we do with those people? I'm going to be sending them to a neuro-optometrist from now on.
What other options are there? We really do have to come up with some good answers for what we do with these people.